Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 328.00
+13.00 (4.13%)
At close: Mar 6, 2026
Carna Biosciences Market Cap
Carna Biosciences has a market cap or net worth of 6.29 billion as of March 6, 2026. Its market cap has increased by 13.24% in one year.
Market Cap
6.29B
Enterprise Value
6.49B
Revenue
579.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
328.00
Market Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has increased from 4.63B to 6.29B, an increase of 36.00%. That is a compound annual growth rate of 1.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.29B | -7.64% |
| Dec 30, 2025 | 6.81B | 18.93% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADR120S | 7.87B |
| CellSource | 7.57B |
| PRISM BioLab Co.,LTD | 7.46B |
| Chiome Bioscience | 7.43B |
| Linical | 7.11B |
| Noile-Immune Biotech | 6.76B |
| TMS Co., Ltd. | 6.73B |
| Soiken Holdings | 6.57B |